DVS Edition Citation

Shrestha, A, Bashir, T, Achison, M, Adamson, S, Akpan, A, Aspray, T, Avenell, A, Band, M. M., Burton, L. A., Cvoro, V, Donnan, P. T., Duncan, G. W., George, Gordon, A. L., Gregson, C. L., Hapca, A, Hume, C, Jackson, T. A., Kerr, S, Kilgour, A, Masud, T, McKenzie, A, McKenzie, E, Patel, H, Pilvinyte, K, Roberts, H. C., Sayer, A. A., Rossios, C, Smith, K. T., Soiza, R. L., Steves, C. J., Struthers, A. D., Tiwari, D, Whitney, J, Witham, M. D. & Kemp, P. R. (2024). Association of bradykinin receptor 2 (BDKRB2) variants with physical performance and muscle mass: Findings from the LACE sarcopenia trial. PLOS ONE, 19 (8), e0307268. Zugriff am 30.09.2024 unter https://doi.org/10.1371/journal.pone.0307268

APA (7th ed.) Citation

Shrestha, A., Bashir, T., Achison, M., Adamson, S., Akpan, A., Aspray, T., . . . Kemp, P. R. (2024). Association of bradykinin receptor 2 (BDKRB2) variants with physical performance and muscle mass: Findings from the LACE sarcopenia trial. PLOS ONE, 19(8), e0307268.

Chicago Style (17th ed.) Citation

Shrestha, A., et al. "Association of Bradykinin Receptor 2 (BDKRB2) Variants with Physical Performance and Muscle Mass: Findings from the LACE Sarcopenia Trial." PLOS ONE 19, no. 8 (2024): e0307268.

MLA (9th ed.) Citation

Shrestha, A., et al. "Association of Bradykinin Receptor 2 (BDKRB2) Variants with Physical Performance and Muscle Mass: Findings from the LACE Sarcopenia Trial." PLOS ONE, vol. 19, no. 8, 2024, p. e0307268.